July 17 (Reuters) - Nuwellis Inc NUWE.O:
NUWELLIS ANNOUNCES TERMINATION OF REVERSE-HF CLINICAL TRIAL TO FOCUS ON STRATEGIC GROWTH IN OUTPATIENT HEART FAILURE CARE
NUWELLIS INC - TERMINATION NOT RELATED TO DEVICE PERFORMANCE OR SAFETY
NUWELLIS INC - ANTICIPATES $4.0M SAVINGS OVER 2.5 YEARS
Source text: ID:nGNX340Cl5
Further company coverage: NUWE.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.